01.01.2013 | Original Articles
Low somatostatin receptor subtype 2, but not dopamine receptor subtype 2 expression predicts the lack of biochemical response of somatotropinomas to treatment with somatostatin analogs
Erschienen in: Journal of Endocrinological Investigation | Ausgabe 1/2013
Einloggen, um Zugang zu erhalten